The DEA’s June 26 Cannabis Registration Deadline Is 16 Days Away. Fewer Than 500 Businesses Have Signed Up.

The federal clock on cannabis rescheduling has a hard stop: June 26, 2026. That’s the date the DEA set for medical cannabis dispensaries to register under its new Schedule III portal — the regulatory mechanism that, in theory, brings plant-touching operators into compliance with federal law for the first time.

As of early June, according to industry tracking data reviewed by CannabisInquirer, fewer than 500 businesses had enrolled. Across 38 states with active medical cannabis programs and an estimated 15,000 to 18,000 licensed dispensaries, clinics, and vertically integrated operators, that number is a rounding error.

The reasons are complicated, the stakes are real, and the state-by-state picture tells a story the headline enrollment numbers don’t.

What the Portal Actually Does

When the DEA opened the Schedule III registration portal in late April 2026, it created the first formal mechanism for medical cannabis businesses to register as federal controlled-substance handlers — a requirement under the Controlled Substances Act that applies to any Schedule III substance. (DEA Diversion Control Division)

Registration doesn’t legalize recreational cannabis. It doesn’t resolve banking barriers outright. And it doesn’t protect state-licensed operators from federal prosecution if political winds shift. What it does is establish a compliance record — and, according to attorneys tracking the rollout, it may be a prerequisite for a range of future federal benefits including potential access to SBA loans, federal credit card processing, and full 280E tax relief.

The catch, which this publication has reported since April, is that registration also creates a paper trail. Businesses that register are formally acknowledging federal jurisdiction over their operations — a legal posture that makes some operators and their attorneys deeply uncomfortable, particularly in states where recreational sales remain unresolved.

The State-by-State Enrollment Gap

The enrollment gap isn’t uniform. It tracks, in broad strokes, both the size of state medical programs and the sophistication of their compliance infrastructure.

California has the largest number of licensed cannabis businesses in the country — roughly 3,800 active retail licenses as of Q1 2026, according to the California Department of Cannabis Control. Industry sources estimate fewer than 80 California businesses had registered with the DEA portal through early June. The California Cannabis Industry Association has urged members to consult legal counsel before registering, a posture that’s contributed to the slow uptake.

Colorado, which has operated one of the country’s most mature regulatory frameworks since 2010, has seen somewhat higher relative enrollment. Colorado’s Marijuana Enforcement Division tracks roughly 770 licensed retail and medical facilities; estimates suggest roughly 50 to 70 had registered federally as of early June. Colorado operators cite the self-incrimination question and unresolved tax guidance as the primary barriers.

Michigan, the third-largest cannabis market by revenue, presents a different dynamic. Michigan’s Cannabis Regulatory Agency has actively encouraged businesses to monitor the DEA timeline. Still, industry sources in the state estimate fewer than 40 Michigan operators had enrolled as of June 1.

Florida — which has no adult-use market and runs a tightly controlled medical-only system through its licensed MMTC operators — is a notable outlier. Florida’s 22 licensed MMTC operators, which collectively run hundreds of dispensary locations, are among the best-capitalized in the country. At least three MMTCs had registered federally or filed preliminary enrollment paperwork as of late May, according to sources familiar with the process. The state’s vertically integrated structure, where a single license covers cultivation, processing, and retail, may make compliance coordination more tractable than in fragmented markets.

Oklahoma, which has the highest per-capita dispensary count in the nation — more than 2,200 active licenses as of May 2026, per the Oklahoma Medical Marijuana Authority — has seen minimal federal enrollment. Oklahoma’s operators skew small, often independent, and historically operate on thin margins that make compliance counsel an unaffordable luxury.

Why Operators Are Waiting

The calculus for most operators comes down to three factors: legal risk, tax certainty, and trust.

On the legal side, the self-incrimination concern is real. Federal registration means formally telling the DEA where your business is, what it does, and that it handles a controlled substance. Several attorneys advising multistate operators have told clients to hold off until the DEA clarifies its enforcement posture.

On taxes, the IRS and Treasury have promised guidance on 280E relief since rescheduling began — but as of June 10, definitive guidance hasn’t published. Without knowing exactly how federal registration interacts with 280E deductions, operators are making enrollment decisions without a complete financial picture.

On trust, the history is straightforward: the federal government has raided, prosecuted, and forfeited assets from cannabis businesses that operated in full compliance with state law. That history doesn’t disappear because the DEA opens a portal.

“The deadline is June 26,” said one California compliance attorney who requested anonymity due to ongoing client matters. “But compliance deadlines for industries that have operated in legal ambiguity for a decade don’t function the way normal regulatory deadlines do. People are watching to see what happens to the first hundred who register before they become the next thousand.”

What Happens After June 26

The DEA has not publicly stated what happens to medical cannabis businesses that do not register by June 26. The agency’s April guidance described the date as a compliance milestone, not an enforcement trigger — but it left the consequences of non-compliance undefined.

Industry attorneys widely expect a grace period. A full enforcement action against unregistered operators would functionally target the majority of the country’s medical cannabis industry — a politically untenable outcome given the current administration’s stated support for rescheduling.

More likely, according to multiple legal analysts, is that the June 26 date becomes a baseline for future enforcement prioritization: registered businesses get the benefit of the doubt, unregistered businesses get scrutinized first in any subsequent federal action.

That framing is cold comfort in states like Oklahoma, where the average dispensary is a two-person operation with a single location and no general counsel on retainer.

The registration gap is also a data gap. The DEA’s portal doesn’t publish enrollment figures by state. There is no public dashboard, no state-by-state breakdown, no real-time count. The federal government is asking an industry it spent decades prosecuting to trust a process it can barely see.

Sixteen days is not much runway. Based on current enrollment trajectories, the vast majority of the country’s licensed medical cannabis businesses will miss the deadline — not out of defiance, but out of uncertainty that federal regulators have had months to resolve and haven’t.

Jordan Pike covers state data and cannabis policy for CannabisInquirer.com. Sources for enrollment estimates include industry legal briefings, state regulatory agency data, and MJBizDaily market tracking. DEA portal figures are based on publicly available disclosures and industry sources; the DEA does not publish a public enrollment dashboard.